U.S. markets closed
  • S&P Futures

    4,134.25
    -13.50 (-0.33%)
     
  • Dow Futures

    33,884.00
    -78.00 (-0.23%)
     
  • Nasdaq Futures

    12,575.75
    -48.25 (-0.38%)
     
  • Russell 2000 Futures

    1,984.90
    -8.60 (-0.43%)
     
  • Crude Oil

    73.53
    +0.14 (+0.19%)
     
  • Gold

    1,888.20
    +11.60 (+0.62%)
     
  • Silver

    22.44
    +0.04 (+0.18%)
     
  • EUR/USD

    1.0799
    +0.0002 (+0.02%)
     
  • 10-Yr Bond

    3.5320
    +0.1360 (+4.00%)
     
  • Vix

    18.33
    -0.40 (-2.14%)
     
  • GBP/USD

    1.2052
    -0.0005 (-0.04%)
     
  • USD/JPY

    131.8770
    +0.7270 (+0.55%)
     
  • BTC-USD

    22,933.86
    -403.79 (-1.73%)
     
  • CMC Crypto 200

    525.98
    -10.88 (-2.03%)
     
  • FTSE 100

    7,901.80
    +81.64 (+1.04%)
     
  • Nikkei 225

    27,753.16
    +243.70 (+0.89%)
     

Henry Schein to Present at Upcoming Investor Conferences

MELVILLE, N.Y., November 09, 2022--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences:

  • Piper Sandler’s 34th Annual Healthcare Conference at the Lotte New York Palace on November 30, 2022, at 9:00 a.m. Eastern time.

  • Evercore ISI HealthCONx Virtual Conference on December 1, 2022, at 11:20 a.m. Eastern time.

  • Nasdaq 47th Investor Conference at the May Fair Hotel, London, on December 6, 2022, at 10:30 a.m. GMT / 5:30 a.m. Eastern time.

Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221108005871/en/

Contacts

Investors
Ronald N. South
Senior Vice President and Chief Financial Officer
ronald.south@henryschein.com
(631) 845-2802

Graham Stanley
Vice President, Investor Relations and Strategic Financial Project Officer
graham.stanley@henryschein.com
(631) 843-5963

Media
Ann Marie Gothard
Vice President, Global Corporate Media Relations
annmarie.gothard@henryschein.com
(631) 390-8169